Glaxo says its HPV shot outperforms Merck's When GlaxoSmithKline announced that it would unveil head-to-head trial data on its HPV vaccine long after the fact and at a lesser-known meeting, folks speculated that the drugmaker might be embarrassed of the trial's outcome. Not … [Read more...] about Glaxo Claims Cervarix More Effective Than Gardasil
Gardasil
Financial Analysts Judge Merck and Glaxo Sales Growth
Will New Results on Merck and GSK's HPV Vaccines Ignite Sales Growth? May 10, 2009 | about stocks: GSK / MRK Mike Huckman is CNBC’s Pharmaceutical Reporter covering the drug, biotechnology and medical device industries. Huckman is based at the network’s global headquarters in … [Read more...] about Financial Analysts Judge Merck and Glaxo Sales Growth
M-Words: Merck, Money, Market Share
Merck and Glaxo Fight for Increased HPV-Vaccine Sales HPV vaccines were a hot topic during the 25th International Papillomavirus Conference, held May 8-14 in Malmö, Sweden. In the weeks leading up to the big event, Glaxo’s PR machine has been touting new Cervarix vs. Gardasil … [Read more...] about M-Words: Merck, Money, Market Share
Merck Press Release
Studies of GARDASIL, Merck's Cervical Cancer Vaccine, and HPV 16 Vaccine Component of GARDASIL Presented at Conference Posted May 11, 2009 Studies of GARDASIL, Merck's Cervical Cancer Vaccine, and HPV 16 Vaccine Component of GARDASIL Presented at International … [Read more...] about Merck Press Release
German and Scottish Health Officials Review HPV Vaccine Programs
Cervical Cancer Jabs Cast Into Doubt After Experts Question Effectiveness SCOTLAND'S multimillion-pound cervical cancer vaccination programme was thrown into doubt last night after senior public health experts warned it might not be as effective as initially hoped. Government … [Read more...] about German and Scottish Health Officials Review HPV Vaccine Programs